Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 22-Apr-24 5:23 PM View:  | Struthers Richard Scott President & CEO Director | Crinetics Pharmaceuticals, ... (CRNX) | 18-Apr-24 | Gift | 350 | -- | -- | (< 1%) 1.16M to 1.16M | |
| 17-Apr-24 4:30 PM View: | Struthers Richard Scott President & CEO Director | Crinetics Pharmaceuticals, ... (CRNX) | 15-Apr-24 | Option Exercise | 20,000 | $1.91 | $38,200.00 | 2% 1.14M to 1.16M | |
| 17-Apr-24 4:36 PM View: | Pizzuti Dana Chief Med and Dev Officer | Crinetics Pharmaceuticals, ... (CRNX) | 15-Apr-24 | Option Exercise | 14,375 | $16.89 | $242,794.00 | 52% 27.79K to 42.16K | |
| 17-Apr-24 4:36 PM View: | Pizzuti Dana Chief Med and Dev Officer | Crinetics Pharmaceuticals, ... (CRNX) | 15-Apr-24 | Planned Option Sale | 14,375 | $44.47 | $639,256.00 | (34%) 42.16K to 27.79K | |
| 08-Apr-24 5:09 PM View: | Struthers Richard Scott President & CEO Director | Crinetics Pharmaceuticals, ... (CRNX) | 04-Apr-24 | Planned Option Sale | 40,951 | $49.17 | $2,013,560.00 | (3%) 1.18M to 1.14M | |
| 08-Apr-24 5:09 PM View: | Struthers Richard Scott President & CEO Director | Crinetics Pharmaceuticals, ... (CRNX) | 04-Apr-24 | Option Exercise | 40,951 | $9.28 | $380,025.00 | 4% 1.14M to 1.18M | |
| 02-Apr-24 4:35 PM View: | Okey Stephanie Director | Crinetics Pharmaceuticals, ... (CRNX) | 28-Mar-24 | Option Exercise | 17,500 | $18.29 | $320,075.00 | 292% 6.0K to 23.5K | |
| 02-Apr-24 4:35 PM View: | Okey Stephanie Director | Crinetics Pharmaceuticals, ... (CRNX) | 28-Mar-24 | Option Sale | 17,500 | $46.38 | $811,650.00 | (74%) 23.5K to 6.0K | |
| 26-Mar-24 4:30 PM View: | Knight Jeff E. Chief Operating Officer | Crinetics Pharmaceuticals, ... (CRNX) | 22-Mar-24 | Private Option Sale | 30,000 | $44.31 | $1,329,160.00 | (35%) 84.94K to 54.94K | |
| 26-Mar-24 4:30 PM View: | Knight Jeff E. Chief Operating Officer | Crinetics Pharmaceuticals, ... (CRNX) | 22-Mar-24 | Sale | 2,359 | $44.31 | $104,516.00 | (4%) 54.94K to 52.58K | |
| 26-Mar-24 4:30 PM View: | Knight Jeff E. Chief Operating Officer | Crinetics Pharmaceuticals, ... (CRNX) | 22-Mar-24 | Option Exercise | 30,000 | $23.98 | $719,400.00 | 55% 54.94K to 84.94K | 4% |
| 22-Mar-24 4:31 PM View: | Fust Matthew K Director | Crinetics Pharmaceuticals, ... (CRNX) | 20-Mar-24 | Option Exercise | 60,000 | $20.92 | $1,254,980.00 | 324% 18.54K to 78.54K | |
| 22-Mar-24 4:52 PM View: | Pizzuti Dana Chief Med and Dev Officer | Crinetics Pharmaceuticals, ... (CRNX) | 20-Mar-24 | Option Sale | 14,375 | $44.06 | $633,307.00 | (34%) 42.88K to 28.5K | |
| 22-Mar-24 4:31 PM View: | Fust Matthew K Director | Crinetics Pharmaceuticals, ... (CRNX) | 20-Mar-24 | Planned Option Sale | 60,000 | $44.14 | $2,648,150.00 | (76%) 78.54K to 18.54K | |
| 22-Mar-24 4:52 PM View: | Pizzuti Dana Chief Med and Dev Officer | Crinetics Pharmaceuticals, ... (CRNX) | 20-Mar-24 | Option Exercise | 14,375 | $16.89 | $242,794.00 | 50% 28.5K to 42.88K | |
| 22-Mar-24 4:52 PM View: | Pizzuti Dana Chief Med and Dev Officer | Crinetics Pharmaceuticals, ... (CRNX) | 20-Mar-24 | Sale | 714 | $44.06 | $31,456.10 | (3%) 28.5K to 27.79K | |
| 20-Mar-24 6:32 PM View: | Wilson Marc CFO | Crinetics Pharmaceuticals, ... (CRNX) | 19-Mar-24 | Sale (Planned) | 6,942 | $42.91 | $297,881.00 | (6%) 117.57K to 110.63K | |
| 20-Mar-24 6:33 PM View: | Betz Stephen F. Chief Scientific Officer | Crinetics Pharmaceuticals, ... (CRNX) | 18-Mar-24 | Payment of Exercise | 3,655 | $38.14 | $139,402.00 | (4%) 96.3K to 92.64K | |
| 20-Mar-24 6:36 PM View: | Pizzuti Dana Chief Med and Dev Officer | Crinetics Pharmaceuticals, ... (CRNX) | 18-Mar-24 | Payment of Exercise | 411 | $38.14 | $15,675.50 | (1%) 28.91K to 28.5K | |
| 20-Mar-24 6:34 PM View: | Hassard James Chief Commercial Officer | Crinetics Pharmaceuticals, ... (CRNX) | 18-Mar-24 | Payment of Exercise | 1,741 | $38.14 | $66,401.70 | (6%) 31.0K to 29.26K | |
| 20-Mar-24 6:35 PM View: | Knight Jeff E. Chief Operating Officer | Crinetics Pharmaceuticals, ... (CRNX) | 18-Mar-24 | Payment of Exercise | 4,283 | $38.14 | $163,354.00 | (7%) 59.22K to 54.94K | |
| 20-Mar-24 6:31 PM View: | Struthers Richard Scott President & CEO Director | Crinetics Pharmaceuticals, ... (CRNX) | 18-Mar-24 | Payment of Exercise | 12,687 | $38.14 | $483,882.00 | (1%) 1.15M to 1.14M | |
| 20-Mar-24 6:32 PM View: | Wilson Marc CFO | Crinetics Pharmaceuticals, ... (CRNX) | 18-Mar-24 | Payment of Exercise | 3,983 | $38.14 | $151,912.00 | (3%) 121.56K to 117.57K | |
| 06-Mar-24 10:00 PM View: | Betz Stephen F. Chief Scientific Officer | Crinetics Pharmaceuticals, ... (CRNX) | 04-Mar-24 | Grant | 23,000 | -- | -- | 31% 73.3K to 96.3K | |
| 06-Mar-24 10:00 PM View: | Wilson Marc CFO | Crinetics Pharmaceuticals, ... (CRNX) | 04-Mar-24 | Grant | 25,500 | -- | -- | 27% 96.06K to 121.56K | |
| 06-Mar-24 10:00 PM View: | Knight Jeff E. Chief Operating Officer | Crinetics Pharmaceuticals, ... (CRNX) | 04-Mar-24 | Grant | 23,000 | -- | -- | 63% 36.22K to 59.22K | |
| 06-Mar-24 10:00 PM View: | Struthers Richard Scott President & CEO Director | Crinetics Pharmaceuticals, ... (CRNX) | 04-Mar-24 | Grant | 65,000 | -- | -- | 6% 1.09M to 1.15M | |
| 06-Mar-24 10:00 PM View: | Pizzuti Dana Chief Med and Dev Officer | Crinetics Pharmaceuticals, ... (CRNX) | 04-Mar-24 | Grant | 23,000 | -- | -- | 389% 5.91K to 28.91K | |
| 14-Feb-24 4:28 PM View: | Struthers Richard Scott President & CEO Director | Crinetics Pharmaceuticals, ... (CRNX) | 12-Feb-24 | Gift | 60,000 | -- | -- | 6% 1.09M to 1.15M | |
| 14-Feb-24 4:28 PM View: | Struthers Richard Scott President & CEO Director | Crinetics Pharmaceuticals, ... (CRNX) | 12-Feb-24 | Gift | 60,000 | -- | -- | (5%) 1.15M to 1.09M | |
| 26-Jan-24 5:50 PM View: | Betz Stephen F. Chief Scientific Officer | Crinetics Pharmaceuticals, ... (CRNX) | 25-Jan-24 | Private Sale (Planned) | 3,000 | $37.26 | $111,780.00 | (4%) 76.3K to 73.3K | |
| 12-Jan-24 4:12 PM View: | Betz Stephen F. Chief Scientific Officer | Crinetics Pharmaceuticals, ... (CRNX) | 10-Jan-24 | Private Sale (Planned) | 3,000 | $37.65 | $112,950.00 | (4%) 79.3K to 76.3K | |
| 04-Jan-24 4:45 PM View: | Pizzuti Dana Chief Med and Dev Officer | Crinetics Pharmaceuticals, ... (CRNX) | 03-Jan-24 | Planned Option Sale | 14,375 | $35.00 | $503,125.00 | (71%) 20.29K to 5.91K | |
| 04-Jan-24 4:45 PM View: | Pizzuti Dana Chief Med and Dev Officer | Crinetics Pharmaceuticals, ... (CRNX) | 03-Jan-24 | Option Exercise | 14,375 | $16.89 | $242,794.00 | 243% 5.91K to 20.29K | |
| 04-Jan-24 4:43 PM View: | Wilson Marc CFO | Crinetics Pharmaceuticals, ... (CRNX) | 02-Jan-24 | Planned Option Sale | 10,000 | $35.47 | $354,700.00 | (9%) 106.06K to 96.06K | |
| 04-Jan-24 4:43 PM View: | Wilson Marc CFO | Crinetics Pharmaceuticals, ... (CRNX) | 02-Jan-24 | Option Exercise | 10,000 | $9.28 | $92,800.00 | 10% 96.06K to 106.06K | |
| 27-Dec-23 5:20 PM View: | Betz Stephen F. Chief Scientific Officer | Crinetics Pharmaceuticals, ... (CRNX) | 26-Dec-23 | Private Sale (Planned) | 3,000 | $35.89 | $107,670.00 | (4%) 82.3K to 79.3K | |
| 22-Dec-23 6:45 PM View: | Pizzuti Dana Chief Med and Dev Officer | Crinetics Pharmaceuticals, ... (CRNX) | 21-Dec-23 | Option Sale | 9,583 | $34.57 | $331,284.00 | (62%) 15.49K to 5.91K | |
| 22-Dec-23 6:45 PM View: | Pizzuti Dana Chief Med and Dev Officer | Crinetics Pharmaceuticals, ... (CRNX) | 21-Dec-23 | Option Exercise | 9,583 | $16.89 | $161,857.00 | 162% 5.91K to 15.49K | |
| 13-Dec-23 4:44 PM View: | Betz Stephen F. Chief Scientific Officer | Crinetics Pharmaceuticals, ... (CRNX) | 11-Dec-23 | Private Sale (Planned) | 3,000 | $32.87 | $98,610.00 | (4%) 85.3K to 82.3K | |
| 29-Nov-23 4:31 PM View: | Betz Stephen F. Chief Scientific Officer | Crinetics Pharmaceuticals, ... (CRNX) | 27-Nov-23 | Private Sale (Planned) | 3,000 | $31.84 | $95,520.00 | (3%) 88.3K to 85.3K | |
| 12-Feb-24 10:00 PM View: | Knight Jeff E. Chief Operating Officer | Crinetics Pharmaceuticals, ... (CRNX) | 20-Nov-23 | Acquisition (other) | 931 | $14.98 | $13,946.40 | 3% 35.29K to 36.22K | |
| 13-Nov-23 4:33 PM View: | Struthers Richard Scott President & CEO Director | Crinetics Pharmaceuticals, ... (CRNX) | 09-Nov-23 | Option Exercise | 50,000 | $1.91 | $95,500.00 | 5% 1.04M to 1.09M | |
| 06-Nov-23 6:02 PM View: | Struthers Richard Scott President & CEO Director | Crinetics Pharmaceuticals, ... (CRNX) | 03-Nov-23 | Option Exercise | 199,082 | $9.28 | $1,847,480.00 | 19% 1.04M to 1.24M | |
| 06-Nov-23 6:02 PM View: | Struthers Richard Scott President & CEO Director | Crinetics Pharmaceuticals, ... (CRNX) | 03-Nov-23 | Option Sale | 199,082 | $30.56 | $6,083,950.00 | (16%) 1.24M to 1.04M | |
| 06-Nov-23 6:02 PM View: | Struthers Richard Scott President & CEO Director | Crinetics Pharmaceuticals, ... (CRNX) | 02-Nov-23 | Option Exercise | 918 | $9.28 | $8,519.04 | < 1% 1.04M to 1.04M | |
| 06-Nov-23 6:02 PM View: | Struthers Richard Scott President & CEO Director | Crinetics Pharmaceuticals, ... (CRNX) | 02-Nov-23 | Option Sale | 918 | $29.95 | $27,494.10 | (< 1%) 1.04M to 1.04M | |
| 03-Nov-23 7:38 PM View: | Wilson Marc CFO | Crinetics Pharmaceuticals, ... (CRNX) | 01-Nov-23 | Option Exercise | 10,000 | $9.28 | $92,800.00 | 10% 95.6K to 105.6K | |
| 03-Nov-23 7:38 PM View: | Wilson Marc CFO | Crinetics Pharmaceuticals, ... (CRNX) | 01-Nov-23 | Option Sale | 10,000 | $28.75 | $287,500.00 | (9%) 105.6K to 95.6K | |
| 19-Oct-23 5:01 PM View: | Krasner Alan Seth Chief Medical Officer | Crinetics Pharmaceuticals, ... (CRNX) | 17-Oct-23 | Option Sale | 7,000 | $30.00 | $210,000.00 | (14%) 50.21K to 43.21K |
